- Home
- IMRN vs CNFR Comparison
IMRN vs CNFR Comparison
Compare IMRN & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- CNFR
- Stock Information
- Founded
- IMRN 1994
- CNFR 2009
- Country
- IMRN Australia
- CNFR United States
- Employees
- IMRN N/A
- CNFR N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- CNFR Property-Casualty Insurers
- Sector
- IMRN Health Care
- CNFR Finance
- Exchange
- IMRN Nasdaq
- CNFR Nasdaq
- Market Cap
- IMRN 9.2M
- CNFR 9.9M
- IPO Year
- IMRN N/A
- CNFR 2015
- Fundamental
- Price
- IMRN $1.92
- CNFR $1.24
- Analyst Decision
- IMRN Strong Buy
- CNFR
- Analyst Count
- IMRN 1
- CNFR 0
- Target Price
- IMRN $5.00
- CNFR N/A
- AVG Volume (30 Days)
- IMRN 41.7K
- CNFR 2.6M
- Earning Date
- IMRN 08-29-2025
- CNFR 08-13-2025
- Dividend Yield
- IMRN N/A
- CNFR N/A
- EPS Growth
- IMRN N/A
- CNFR N/A
- EPS
- IMRN N/A
- CNFR 2.45
- Revenue
- IMRN $4,777,422.00
- CNFR $52,654,000.00
- Revenue This Year
- IMRN N/A
- CNFR $25.91
- Revenue Next Year
- IMRN N/A
- CNFR N/A
- P/E Ratio
- IMRN N/A
- CNFR $0.54
- Revenue Growth
- IMRN 48.63
- CNFR N/A
- 52 Week Low
- IMRN $1.50
- CNFR $0.42
- 52 Week High
- IMRN $2.87
- CNFR $2.21
- Technical
- Relative Strength Index (RSI)
- IMRN 56.80
- CNFR 53.11
- Support Level
- IMRN $1.85
- CNFR $1.49
- Resistance Level
- IMRN $1.94
- CNFR $2.21
- Average True Range (ATR)
- IMRN 0.08
- CNFR 0.26
- MACD
- IMRN 0.00
- CNFR 0.01
- Stochastic Oscillator
- IMRN 86.67
- CNFR 35.25
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.